Singapore markets closed
Straits Times Index
3,303.66 +12.96 (+0.39%) S&P 500
5,228.48 +5.80 (+0.11%) Dow
39,628.33 +115.49 (+0.29%) Nasdaq
16,355.86 +15.00 (+0.09%) Bitcoin USD
62,750.45 +1,613.23 (+2.64%) CMC Crypto 200
1,291.94 +31.74 (+2.52%)
Esperion Therapeutics, Inc. (0ET.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
As of 08:10AM CEST. Market open.
| Previous close | 1.7650 |
| Open | 1.8320 |
| Bid | 2.0530 x N/A |
| Ask | 2.1530 x N/A |
| Day's range | 1.8320 - 1.8320 |
| 52-week range | 0.6660 - 2.9880 |
| Volume | |
| Avg. volume | 113 |
| Market cap | 399.506M |
| Beta (5Y monthly) | 0.82 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Esperion (ESPR) Q1 Earnings Beat, Stock Up on Strong Revenues
Esperion's (ESPR) first-quarter earnings and sales beat estimates on the back of better-than-expected collaboration revenues.
- Insider Monkey
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q1 2024 Earnings Call Transcript
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q1 2024 Earnings Call Transcript May 7, 2024 Esperion Therapeutics, Inc. beats earnings expectations. Reported EPS is $0.00032, expectations were $-0.17. ESPR isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies and gentlemen, thank you for […]
- GuruFocus.com
Esperion Therapeutics Inc (ESPR) Q1 2024 Earnings Call Transcript Highlights: Soaring Revenues ...
Discover how Esperion Therapeutics achieved a historic revenue milestone and expanded market potential in its first quarter of 2024.
© 2024 Yahoo. All rights reserved.